Parkinson’s drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of potentially harmful bacteria like E. coli, reports a new study. The findings mean that ...
In a groundbreaking new study scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The ...
In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive Planetary Health", scientists from the University of Vienna, in collaboration ...